FDA clears a 510(k) submitted by Belgium-based Sunrise for its second generation at-home sleep apnea test that uses artificial intelligence to aid in ...
Two Morgan Lewis attorneys explore decisions facing FDA in light of an 11th Circuit Court of Appeals ruling on orphan drug exclusivity that FDA disagr...
AdvaMed suggests changes to an FDA draft guidance on delaying, denying, limiting, or refusing a drug or device inspection.
A joint FDA advisory committee meeting votes to recommend the nonprescription use of Emergent BioSolutions Narcan (naloxone HCl) nasal spray for treat...
Federal Register notice: FDA sends to OMB an information collection revision entitled Medical Device Labeling Requirements; Unique Device Identificati...
Federal Register notice: FDA makes available a draft guidance entitled Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neon...
FDA issues Soligenix a refuse-to-file letter for its HyBryte (synthetic hypericin) NDA that is seeking an indication for treating early stage cutaneou...
FDA warns Tuzia/Istanbul, Turkey-based Delta Kozmetik about CGMP violations in its production of finished drugs.
